Table 3. Segmented regression analysis of the test positivity of respiratory viruses.
| Respiratory viruses | Final ARMA models | Intercept (γ0) | Preslope (γ1) | Intervention (γ2) | Postslope (γ3) | p-value (γ3) |
|---|---|---|---|---|---|---|
| RSV | ARMA (2,1) | 5.066 | -0.005 | -0.410 | -0.134 | p = 0.001 |
| PIV | ARMA (2,2) | 4.684 | -0.007 | 0.017 | -0.076 | p = 0.013 |
| ADV | ARMA (1,1) | 2.174 | -0.002 | -0.711 | -0.015 | p = 0.145 |
| MPV | ARMA (2,2) | 2.818 | -0.003 | 0.068 | -0.053 | p = 0.028 |
| RV/EV | ARMA (1,0) | 19.981 | -0.023 | -1.440 | -0.125 | p = 0.226 |
| COV | ARMA (1,1) | 3.169 | -0.005 | 1.846 | -0.131 | p<0.001 |
| IFV | ARMA (3,0) | 9.314 | 0.006 | 1.613 | -0.388 | p<0.001 |
| Overall | ARMA (1,0) | 46.996 | -0.035 | -1.835 | -0.946 | p<0.001 |
Autoregressive–moving-average (ARMA; p, q), Respiratory syncytial virus (RSV), parainfluenza virus (PIV), adenovirus (ADV), human metapneumovirus (MPV), human rhinovirus/enterovirus (RV/EV), seasonal human coronavirus (COV), and influenza A/B (IFV).